Skip to main content
OpenTrials

Clinical trial condition

Elevated Tumor-Infiltrating Lymphocytes

Explore clinical trials studying Elevated Tumor-Infiltrating Lymphocytes. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Elevated Tumor-Infiltrating Lymphocytes trial results

Recruiting

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

NCT07743190

Conditions
Breast Diseases, Breast Neoplasms, Elevated Tumor-Infiltrating Lymphocytes, +6 more
Locations
  • SUNY Upstate Medical University Syracuse, New York, United States
  • Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina, United States
View Trial Details

Related conditions